State Ledger
Company profile

Viridian Therapeutics, Inc.\DE CIK 1590750

Ticker
VRDN (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Waltham, MA 02453
Fiscal year end
2025 (FY)
Market Data
Close
$18.24
Change
-$0.07
Change %
-0.36%
Volume
158,561

VRDN · trading date Oct 13, 2026 · previous close $18.30 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$342.60M
Total assets
$899.42M
Total liabilities
$177.25M
Stockholders' equity
$722.17M
Cash & equivalents
$212.38M
Operating income
-$363.40M
Operating cash flow
-$276.39M
Capital expenditures
$495.0K

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$276.89M
Free cash flow margin
—
Liabilities / assets
19.7%
Equity / assets
80.3%
CapEx / revenue
—
Operating cash flow / net income
0.81×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$342.60M $899.42M $177.25M $722.17M
2024 — -$269.95M $742.40M $70.76M $671.64M
2023 — -$237.73M $490.42M $48.40M $442.02M
2022 — -$129.87M $435.09M $40.03M $395.06M
2021 — -$79.41M $203.71M $15.99M $187.72M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-20
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Waltham, MA 02453
221 CRESCENT STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies